Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Coeptis Therapeutics Holdings, Inc. - Common Stock
(NQ:
COEP
)
9.810
UNCHANGED
Streaming Delayed Price
Updated: 9:42 AM EDT, May 19, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Coeptis Therapeutics Holdings, Inc. - Common Stock
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
May 05, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders
May 01, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
May 01, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
April 30, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders
April 25, 2025
From
Halper Sadeh LLC
Via
Business Wire
COEPTIS (COEP) Expands Global Footprint with Strategic India Tech Hub
April 22, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Biotech Bright Spots: Coeptis Therapeutics (COEP) And 3 Hidden Treasures
February 21, 2024
Via
Get News
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
April 25, 2025
Aim to create the largest publicly-traded, Dogecoin-focused mining company in the world Coeptis to spin out biopharmaceutical operations
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
April 17, 2025
Strategic Collaboration Enhances Access to Cutting-Edge AI, Blockchain Solutions, Biopharma & Defense Technologies
From
Coeptis Therapeutics
Via
GlobeNewswire
Coeptis (NASDAQ: COEP) Accelerates Growth with Strategic Partnerships and Innovation
March 17, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Coeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy License
March 14, 2025
Via
AB Newswire
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
March 11, 2025
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
March 07, 2025
Leveraging Advanced AI and Robotics to Revolutionize Marketing Strategies in Defense and Security Sectors
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
February 20, 2025
The Strategic Collaboration Integrates Cutting-Edge Marketing Tools into the ValuSocial Platform, Leveraging the Robust Capabilities of Verus Coin and Blockchain Technology
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
February 20, 2025
This partnership gives COEPTIS access to AI-driven campaign management, predictive analytics, and automated outreach capabilities with MarketLeverage’s 5,500 advertisers and 55,000 publishers, creating...
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
February 19, 2025
This partnership gives COEPTIS access to AI-driven campaign management, predictive analytics, and automated outreach capabilities with MarketLeverage’s 5,500 advertisers and 55,000 publishers, creating...
From
Coeptis Therapeutics
Via
GlobeNewswire
Coeptis Therapeutics (Nasdaq: COEP) Emerges as a Biopharma Innovator Leveraging AI-Driven Marketing
January 17, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Biotech Innovation: Coeptis Therapeutics (COEP) And 3 Companies Changing The Game
February 21, 2024
Via
Get News
These are the 4 hottest stocks insiders bought in January
January 29, 2024
Insiders are buying these stocks, but not all are good buys for investors or bullish traders; avoid stocks with high short interest, no revenue, and no earnings
Via
MarketBeat
Potential acquisition of VyGen-Bio would Strengthen Coeptis Therapeutics (NASDAQ: COEP) oncology pipeline by obtaining exclusive, worldwide ownership rights to GEAR™ Platform
March 31, 2023
Via
Get News
Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics (NASDAQ: COEP)
March 29, 2023
Via
Get News
BioMedNewsBreaks – Coeptis Therapeutics Holdings Inc. (NASDAQ: COEP) Tech Spotlighted in Article in Peer-Reviewed Translational Medicine Journal
March 22, 2023
Via
Investor Brand Network
Translational Medicine Journal Features Multi-Antigen CAR T Technology, Cell Therapy, and In Vitro Diagnostics with Multiple Cancer Types: Coeptis Therapeutics Holdings, Inc (NASDAQ: COEP)
March 21, 2023
Via
Get News
Coeptis Therapeutics Holdings, Inc (NASDAQ: COEP) to Collaborate with the University of Pittsburgh to expand pre-clinical Development of SNAP-CAR T Cells Targeting HER2-Positive Cancers
February 07, 2023
Via
Get News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.